Features
An Update on Implantable IOP Monitoring
New data represent a giant leap forward.
By Lance J. Lyons, MD, Arthur J. Sit, MD
The Effect of Mask Wearing on Reliability of Goldmann Applanation Tonometry
The Effect of Mask Wearing on Reliability of Goldmann Applanation Tonometry
By Leonard K. Seibold, MD, MALIK KAHOOK, M.D., Deidre St. Peter, MD
Myths Associated With Optical Coherence Tomography for Glaucoma
A conversation with Donald C. Hood, PhD
By Jennifer Ford, content director
The Current Landscape of Visual Field Technologies
Virtual reality is changing the glaucoma game.
By Bradley A. Daniel, OD, FAAO, Steven R. Sarkisian, Jr., MD
Xen for Both Open-conjunctiva and Closed-conjunctiva MIGS
Two approved approaches keep options open - and closed - for individual cases and surgeons.
By Davinder S. Grover, MD, MPH, Joseph F. Panarelli, MD
Web Exclusives
The Lasting Impact of the Pandemic on Glaucoma Management
Changes made by necessity will persist far into the future.
By Natasha Nayak Kolomeyer, MD,, Jonathan S. Myers, M.D., Douglas
Online Pharmacies Shine in the Era of COVID-19
Physicians and patients have another health-care partner.
By Rene Luthe
Departments
From the Editor: A Billion Ways to Treat Glaucoma
By Nathan Radcliffe, MD
Coding: To Dilate or Not To Dilate
Glaucoma specialists must ask themselves this important question.
By Kevin J. Corcoran, COE, FNAO
Product Spotlight: Olleyes Virtual Reality Platform Makes Visual Field Testing at Home a Reality
Comfort and ease of use are among its attributes.
By Karen Appold, contributing writer
News
Sustained-release iDose TR Controls IOP at 2 Years
By Jerry Helzner, contributing editor
Home Glaucoma Monitoring Proves Effective
By Jerry Helzner, contributing editor
iStent Infinite Effective in Difficult-to-Treat Patients
By Jerry Helzner, contributing editor
Aerpio Says Glaucoma Drug Effective in Phase 2
By Jerry Helzner, contributing editor
Drive-through IOP Screening During COVID Pandemic
By Jerry Helzner, contributing editor
Glaucoma Drug Safer as Once-daily Therapy
By Jerry Helzner, contributing editor
GRF Video Reassures Patients of Safe Glaucoma Care
By Jerry Helzner, contributing editor
Major Patient-reported Glaucoma Survey Initiated
By Jerry Helzner, contributing editor
Large-scale Study Finds Benefits From Gonioscopy
By Jerry Helzner, contributing editor
Central vs Peripheral Damage in Assessing Functional Disability
By Jerry Helzner, contributing editor
Ocular Therapeutix Sees Promise in Travoprost Implant
By Jerry Helzner, contributing editor
A Novel Eye-Drop Delivery Device
By Jerry Helzner, contributing editor